Full Text
Full Text PDF
Abstract
Abstract
Metamizole, a non-steroidal anti-inflammatory drug with weak anti-inflammatory and spasmolytic effects, is used as an analgesic and antipyretic agent. Many adverse reactions to metamizole, such as early or late-onset systemic reactions and bone marrow suppression, have been identified. In this report, we present a case of systemic reaction after the application of parenteral metamizole (Novalgin® ampoule; Sanofi Aventis, İstanbul, Turkey) and discuss the mechanism underlying the reaction.
Similar Articles
Article Info
Published In
Journal
The Eurasian Journal of Medicine
Volume / Issue
Volume 48 · Issue 2 · January 2016
Pages
145-148
History
Published Online
September 3, 2019
Copyright
Copyright (c) 2016 The Eurasian Journal of Medicine
Affiliations
Sevket Arslan
Division of Immunology and Allergic Disease
Ramazan Ucar
Division of Immunology and Allergic Disease
Ahmet Zafer Caliskaner
Division of Immunology and Allergic Disease
Cite this Article
Arslan, S., Ucar, R., & Caliskaner, A. Z. (2019). IgE-Mediated Reaction to Metamizole: Evaluation of a Patient with Severe Anaphylaxis. The Eurasian Journal of Medicine, 48(2), 145–148. https://doi.org/10.5152/eurasianjmed.2015.0024
Outlines